- Editor's PickYahoo Finance•18 hours ago
Catch The Final Round with Jen Rogers and markets correspondent Nicole Sinclair. Stocks in the green today include Stemline Therapeutics after the FDA granted Breakthrough status for its acute myeloid leukemia treatment, software maker Tableau as it appointed former Amazon exec Adam Selipsky as its new CEO, and Monsanto – shares of the seed and chemical-maker growing after Bloomberg reported Bayer and Monsanto were working on an improved takeover bid. Hillary Clinton’s presidential campaign has been dogged by accusations that wealthy Clinton Foundation donors sought favors from the State Department when Clinton was at its head.
- Editor's PickYahoo Finance•yesterday
Wall Street seems to have its mojo back. Stocks (^DJI, ^GSPC, ^IXIC) are sharply higher across the board with the Nasdaq at a fresh intraday high following some better-than-expected earnings from Best Buy (BBY) and Toll Brothers (TOL). Meanwhile, oil prices (CL=F) are lower again following last week’s rally.
- American City Business Journals•1 hour ago
Lawsuits in which three California cities sought to make Creve Coeur-based Monsanto Co. pay to help reduce PCB contamination in San Francisco Bay were dismissed by a federal judge. U.S. District Judge Edward Davila on Monday ruled that the cities of San Jose, Oakland and Berkeley didn't show that the company's sale decades ago of products that contained PCBs (polychlorinated biphenyls) caused a public nuisance that damaged their property rights, Reuters reports . Monsanto, which produced PCBs from 1935 to 1977, was the only domestic maker of PCBs, which were outlawed by the U.S. government in 1979.
Monsanto Company (MON)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||107.65 x 200|
|Ask||107.99 x 100|
|Day's Range||107.22 - 107.87|
|52wk Range||81.22 - 114.26|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||47.31|
|Avg Vol (3m)||4,169,328|
|Dividend & Yield||2.16 (2.07%)|